Below benchmark for 1st month, page-47

Her response. "Its application is significantly wider than what its currently being used to treat, due to the nature of its regeneration approach"

In many ways we dont know yet what the long term potential is here to address multiple conditions" ....

... translated in my ears to ...

Sp currently is only based on specific market cap of one addressable treatment and then the usual equations. Its application potential is truly unknown but for the purposes of getting it to market you keep it simple.

My own academic background is in biochemistry hence why i could have a relatively good depth of discussion.

What neuren have is 1st generation of the product... lets call it the prototype. Because of things like unravelling dna coding, which is a rapidly evolving industry... we will uncover ways to address multiple conditions at the molecular level rather than say symptomatic. Neurens product is one of the 1st treatments that "regenerates" rather than treats. As this opens up a myriad of applications you cant b
Put a long term price target on it.

If it was evolved to phase 2 and cured autism.. what would its worth be then ???
And then what about the other 20, 30, 40 rare conditions that dont have a voice yet ?

Imo neuren for me is a minimum 5 year keeper from now. We've only just begun to understand the brain so as our insights build, so will our sophistication in building non invasive treatment procedures. I see neuren as a global pioneer in this front.

I know there's many hurdles yet to cross and i'm not a professional investor. I didn't care about how funding was raised etc because i knew one way or another we'd get there (my eyes are only on the prize)
Its when i read the science my eyebrow raised. The fda already know this has to move forward but they also have a job to do in regards to public safety.

I dont care if there's delays if its in the pursuit of de-risking fda approval by meticulous work being done. We haven't waited this long to fall ast the last hurdle.

So in summary neuren exists in a realm of its own... thats why sp and volume is pretty stagnant because you can only put a small bet on "potential". I cant even begin to put a target on it as i see the application for its uses continually evolving but with each rendition comes more testing and more trials= more months/years waiting

But it will make a very nice addition to your super fund IF you can wa it that long

Gltah

Long neuren